Funnelfeedr Logo

Abarceo Pharma AB

Sweden559139-7160Active

Developing novel small molecule therapeutics targeting VDAC1 for diabetes.

Biotechnology Companyabarceo.com

Overview

5–9
Employees
2.5–5M SEK
Revenue
2017
Founded

Key Decision Makers

Mozhgan Dorkhan

Consulting CMO

Adam Bruce

CEO

Claes Post

Board Member

Claes Wollheim

CSO & Scientific Founder, Board Member

+11 more contacts in Funnelfeedr

Description

Abarceo Pharma is a pre-clinical stage biotechnology company founded in 2017 as a spin-out from the Lund University Diabetes Center. It was established by world-renowned scientists specializing in diabetes research and beta-cell biology. The company has identified Voltage-Dependent Anion Channel 1 (...

Tags

B2BHealthcarePharmaceuticalsProfessional ServicesWhite Collar

Keywords

BiotechDiabetes TherapeuticsDrug DiscoveryMitochondrial DysfunctionType 2 DiabetesVDAC1 Target

Tech Stack

jQuery MigratejQueryBootstrapPriority HintsWordPressVarnishApache HTTP ServerPHPMagnific PopupFitVids.JSEasy Pie ChartYouTubejQuery Mobile

Company Information

Industry
Bioteknisk forskning och utveckling
Legal Form
Aktiebolag
VAT Number
SE559139716001

Decision Makers

15 contacts in Funnelfeedr

Mozhgan Dorkhan

Consulting CMO

Adam Bruce

CEO

Claes Post

Board Member

Claes Wollheim

CSO & Scientific Founder, Board Member

Per Aniansson

Chairman of the Board

Ulrich Koch

Independent Board Member

William Dalby Brown

Head of Medicinal Chemistry and Screening

Henrik Otendal

CFO

Tara Heitner

Vice Chair

Albert Salehi

Scientific Founder

Jan Alenfall

COO

Other Contacts

Steven Kahn

Scientific Advisor

Michael Karin

Scientific Advisor

Kent Bodensgaard

Scientific Advisor

Ruchi Jain

Principal Scientist

Similar Companies

20 similar companies in Funnelfeedr

Browse More

Abarceo Pharma AB Questions

Want to see Funnelfeedr in action?

Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.

Book a demo